Renalytix AI—developer of artificial intelligence ("AI") decision support and clinical management tools for improving early diagnosis, continual monitoring and drug development for kidney disease. incorporated in March 2018 as a subsidiary of EKF
Diagnostics Holdings (AIM-EKF). Total fundraising in the range £21 - 25 m. Mkt cap - c. £67.5- £71.0m. Due 2 Nov.
Finncap—proposed acquisition of M&A adviser Cavendish Corporate Finance and AIM admission. Offer TBA
Kropz PLC—an emerging plant nutrien ....
30 Oct 2018
Small Cap Feast
Rosslyn Data Technologies PLC (RDT:LON), 9.8 | Hargreaves Services plc (HSP:LON), 573 | Tracsis plc (TRCS:LON), 820 | Ten Lifestyle Group PLC (TENG:LON), 72.8 | LMS Capital PLC GBP (LMS:LON), 17.6 | Aura Energy Limited (AURA:LON), 9.0 | Sunrise Resources plc (SRES:LON), 0.0 | Quadrise PLC (QED:LON), 1.7 | R&Q Insurance Holdings Ltd (RQIH:LON), 2.5
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Small Cap Feast
Rosslyn Data Technologies PLC (RDT:LON), 9.8 | Hargreaves Services plc (HSP:LON), 573 | Tracsis plc (TRCS:LON), 820 | Ten Lifestyle Group PLC (TENG:LON), 72.8 | LMS Capital PLC GBP (LMS:LON), 17.6 | Aura Energy Limited (AURA:LON), 9.0 | Sunrise Resources plc (SRES:LON), 0.0 | Quadrise PLC (QED:LON), 1.7 | R&Q Insurance Holdings Ltd (RQIH:LON), 2.5
- Published:
30 Oct 2018 -
Author:
Derren Nathan - Pages:
Renalytix AI—developer of artificial intelligence ("AI") decision support and clinical management tools for improving early diagnosis, continual monitoring and drug development for kidney disease. incorporated in March 2018 as a subsidiary of EKF
Diagnostics Holdings (AIM-EKF). Total fundraising in the range £21 - 25 m. Mkt cap - c. £67.5- £71.0m. Due 2 Nov.
Finncap—proposed acquisition of M&A adviser Cavendish Corporate Finance and AIM admission. Offer TBA
Kropz PLC—an emerging plant nutrien ....